Autres langues AstraZeneca PLC NYSE

Actions

AZN

US0463531089

Produits pharmaceutiques

Temps réel estimé Cboe BZX 20:55:00 24/07/2026 Varia. 5j. Varia. 1 janv.
168,94 USD +0,40% Graphique intraday de AstraZeneca PLC -0,60% +83,38%

Autres langues

18:12 European Stocks Close Higher Friday; Eurozone Private Sector Expands in July
18:03 Stocks rise as oil price cools on peace talk hope
17:17 TAGESVORSCHAU/Samstag, 25. bis Montag, 27. Juli (vorläufige Fassung)
15:37 AstraZeneca says two treatments backed for EU approval
15:13 WOCHENVORSCHAU/27. Juli bis 2. August 2026 (31. KW)
13:43 AstraZeneca's Trixeo Recommended for EU Approval to Treat Asthma
13:43 AstraZeneca, Daiichi Sankyo's Enhertu Combination Therapy Recommended for EU Approval in Breast Cancer
13:32 AstraZeneca, Daiichi Sankyo's Breast Cancer Therapy Wins European Medicines Agency's Positive Opinion
13:23 AstraZeneca's Trixeo Gets EU Panel Backing for Asthma Maintenance
13:08 AstraZeneca : Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer
12:40 AstraZeneca : Trixeo recommended for approval in the EU by CHMP for the maintenance treatment of asthma
11:19 WINNERS & LOSERS: discoverIE and Renishaw lead way on FTSE 250
09:40 Take Five: A $100 question
08:55 HBM Holdings Expects H1 Profit of Up to $67 Million
23/07 Healthcare Shares Rise on Optimism Around Weight Loss Drugs -- Health Care Roundup
23/07 European Stocks Close Sharply Lower in Thursday Trading; European Central Bank Leaves Rates Unchanged
23/07 Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune
23/07 Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma
23/07 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Major Tech Stocks Sell-Off
23/07 Defensieaandelen in trek op rode Europese beursvloeren
23/07 European Midday Briefing : Oil Hits $98 a Barrel, Shares Fall Ahead of ECB Decision
23/07 AstraZeneca's Etcamah combo approved for breast cancer treatment in EU
23/07 Astrazeneca's Etcamah combination for ESR1-mutated advanced breast cancer
23/07 Oil Tops $98 a Barrel, Tech Earnings Worry Markets
23/07 AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues
Aucun résultat pour cette recherche